Delivery Order SPE2DB22D2211-SPE2DB24FPDH9
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,204.58 and runs through March 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,473,545 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a total ceiling value of $14,200.58 and is a firm fixed-price contract with an ultimate completion date of October 16, 2023. The contract is not designated...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $22,584.93 and a completion date of September 5, 2024. It is a firm fixed-price contract, meaning the price will not change regardless of the contractor's actual costs. This contract is not set aside...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,958,111 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and a total ceiling value of $17,185.18. It is not set aside for any specific type of business. The contract has an ultimate...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting, with a ceiling value of $26,559.23. The contract has an ultimate completion date of March 22, 2023 and is a firm fixed-price delivery order contract. There is no set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,389,524 units of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $24,035.93 and a completion date of February 27, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $1,503.07 and an ultimate completion date of August 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Ondansetron HCL 4 mg tablets, a generic pharmaceutical product used to treat nausea and vomiting. The delivery order has a ceiling value of $6,170.70 and a completion date of September 9, 2024. The contract is a firm fixed price arrangement. AmerisourceBergen, one of the largest pharmaceutical...